Compare Ginkgo Bioworks Holdings Inc (DNA) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Cassava Sciences Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 10.6× Cassava Sciences Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| DNA | FLNA | |
|---|---|---|
Market Cap | $505.73M | $47.75M |
Sector | Health | Health |
52-Week High | $16.14 | $4.64 |
52-Week Low | $5.48 | $0.87 |
Enterprise Value | $607.68M | -$34.93M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
